• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Rhythmia Medical appoints new board member

Rhythmia Medical appoints new board member

December 29, 2009 By MassDevice staff

Rhythmia Medical Inc. lined up some expert help as it steers toward future growth, landing an experienced medical device entrepreneur and executive as the newest addition to its board of directors.

The Burlington, Mass.-based company announced Monday that Michael Dale, chief executive at ATS Medical Inc. in Minneapolis, had agreed to join the Rhythmia board. Dale, 50, has been CEO at ATS Medical since its October, 2002, reorganization, leading the firm through a major overhaul of its manufacturing facility, expanding its sales force and reaching into new markets through acquisitions and strategic partnerships.

Rhythmia officials said that expertise will come in handy as they work to bring the company’s heart-mapping technology to market. In prepared remarks, company co-founder Leon Amariglio cited Dale’s “unique industry perspective” along with “an extensive background in sales, marketing and commercialization” as attributes supporting his selection to the Rhythmia board.

During the past five years, Dale has been a board member at Neuronetics Inc. in Malvern, Pa., a venture-backed firm marketing an FDA-cleared device to treat depression using MRI-strength magnetic fields to stimulate nerve cells in the brain. He also sits on the board of the Advanced Medical Technology Association (AdvaMed), a Washington, D.C.-based trade group. ATS Medical reported $18.8 million in revenues during the three months ended Oct. 3, a seven-fold increase from the $2.5 million in sales recorded during Dale’s first quarter at the helm in 2002.

Rythmia holds several patents, including one issued in May for imaging technology using catheters equipped with multiple sensors to detect electrical activity on the innermost tissue of the heart. The sensors record differences in electrical potential at various locations on the endocardium during the heartbeat cycle, quickly creating a three-dimensional image of chambers in the heart and assisting surgeons in identifying the source of abnormal heartbeats such as arrhythmia.

The company launched in 2004 and has raised about $12 million from institutional and individual investors. It is expected to soon start formal testing of its imaging system in preparation for seeking regulatory approvals, recently beginning a search for a director of clinical and regulatory affairs.

Filed Under: Business/Financial News, News Well

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy